Canada Pension Plan Investment Board’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$54.5M Sell
680,373
-109,746
-14% -$9.05M 0.04% 343
2025
Q4
$67.4M Buy
790,119
+187,249
+31% +$15.4M 0.05% 295
2025
Q3
$46.9M Sell
602,870
-283,161
-32% -$22.1M 0.03% 354
2025
Q2
$69.3M Buy
886,031
+357,166
+68% +$26.6M 0.06% 262
2025
Q1
$38.3M Sell
528,865
-233,875
-31% -$16.7M 0.04% 339
2024
Q4
$56.5M Buy
762,740
+339,299
+80% +$23.7M 0.05% 285
2024
Q3
$27.9M Buy
423,441
+129,105
+44% +$9.38M 0.03% 382
2024
Q2
$27.2M Sell
294,336
-32,776
-10% -$2.9M 0.03% 378
2024
Q1
$31.3M Sell
327,112
-309,251
-49% -$26M 0.03% 367
2023
Q4
$48.5M Buy
636,363
+12,223
+2% +$850K 0.06% 266
2023
Q3
$43.2M Sell
624,140
-22,700
-4% -$1.82M 0.06% 262
2023
Q2
$61M Sell
646,840
-8,000
-1% -$695K 0.09% 212
2023
Q1
$54.2M Sell
654,840
-62,678
-9% -$4.93M 0.09% 216
2022
Q4
$53.5M Buy
717,518
+33,020
+5% +$2.54M 0.09% 202
2022
Q3
$56.6M Buy
684,498
+163,900
+31% +$15.8M 0.1% 201
2022
Q2
$49.5M Sell
520,598
-28,000
-5% -$2.9M 0.08% 219
2022
Q1
$64.6M Sell
548,598
-465,011
-46% -$52.2M 0.09% 228
2021
Q4
$131M Sell
1,013,609
-388,200
-28% -$45.3M 0.14% 163
2021
Q3
$159M Buy
1,401,809
+139,409
+11% +$15.9M 0.18% 130
2021
Q2
$131M Buy
1,262,400
+375,575
+42% +$35.4M 0.16% 153
2021
Q1
$74.2M Buy
886,825
+325,691
+58% +$27.5M 0.1% 208
2020
Q4
$51.2M Sell
561,134
-157,291
-22% -$13M 0.08% 226
2020
Q3
$57.3M Sell
718,425
-74,873
-9% -$5.84M 0.11% 150
2020
Q2
$54.8M Buy
793,298
+528,815
+200% +$37.6M 0.12% 130
2020
Q1
$16.6M Sell
264,483
-478,530
-64% -$34.5M 0.04% 273
2019
Q4
$57.8M Sell
743,013
-11,739
-2% -$917K 0.11% 144
2019
Q3
$55.3M Buy
754,752
+211,968
+39% +$14.9M 0.11% 150
2019
Q2
$33.4M Buy
542,784
+4,920
+0.9% +$298K 0.07% 233
2019
Q1
$34.3M Buy
537,864
+264,303
+97% +$15.1M 0.07% 245
2018
Q4
$14M Sell
273,561
-150,069
-35% -$7.59M 0.03% 455
2018
Q3
$24.6M Buy
423,630
+293,700
+226% +$14.4M 0.05% 335
2018
Q2
$6.3M Sell
129,930
-273,705
-68% -$12.8M 0.01% 736
2018
Q1
$18.8M Buy
403,635
+204,300
+102% +$8.87M 0.03% 429
2017
Q4
$7.49M Buy
199,335
+180,756
+973% +$6.63M 0.01% 598
2017
Q3
$677K Buy
18,579
+16,410
+757% +$626K ﹤0.01% 974
2017
Q2
$85K Sell
2,169
-277,323
-99% -$10.1M ﹤0.01% 1061
2017
Q1
$8.76M Buy
279,492
+279,306
+150,165% +$8.74M 0.02% 484
2016
Q4
$6K Sell
186
-88,776
-100% -$2.88M ﹤0.01% 1048
2016
Q3
$3.58M Sell
88,962
-45,300
-34% -$1.71M 0.01% 600
2016
Q2
$4.46M Sell
134,262
-1,004,514
-88% -$34.4M 0.02% 551
2016
Q1
$33.5M Buy
1,138,776
+831,000
+270% +$22.9M 0.14% 124
2015
Q4
$8.1M Sell
307,776
-527,892
-63% -$13.7M 0.04% 417
2015
Q3
$19.8M Sell
835,668
-196,116
-19% -$4.73M 0.08% 218
2015
Q2
$24.5M Buy
1,031,784
+111,000
+12% +$2.5M 0.08% 219
2015
Q1
$21.9M Sell
920,784
-104,700
-10% -$2.35M 0.08% 245
2014
Q4
$21.8M Buy
1,025,484
+11,940
+1% +$240K 0.07% 267
2014
Q3
$17.3M Buy
1,013,544
+235,260
+30% +$3.71M 0.06% 307
2014
Q2
$11.1M Buy
778,284
+733,398
+1,634% +$9.94M 0.04% 436
2014
Q1
$555K Buy
44,886
+2,928
+7% +$33.8K ﹤0.01% 851
2013
Q4
$460K Sell
41,958
-60,402
-59% -$681K ﹤0.01% 872
2013
Q3
$1.19M Buy
102,360
+17,124
+20% +$200K 0.01% 730
2013
Q2
$955K Buy
+85,236
New +$1.01M ﹤0.01% 646

Other funds holding EW

Canada Pension Plan Investment Board's EW Position: Q1 2026 in Review

Canada Pension Plan Investment Board reduced its Edwards Lifesciences (EW) stake by 14% in Q1 2026, selling an estimated $9.05M and leaving 680,373 shares worth $54.5M. The position accounts for 0.04% of the portfolio, ranked #343.

Canada Pension Plan Investment Board first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $159M in Q3 2021. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Canada Pension Plan Investment Board held 680,373 shares of Edwards Lifesciences worth $54.5M as of Q1 2026.
  • Canada Pension Plan Investment Board sold 109,746 Edwards Lifesciences shares in Q1 2026, an estimated $9.05M.
  • Edwards Lifesciences made up 0.04% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #343 holding.
  • Canada Pension Plan Investment Board first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
  • Canada Pension Plan Investment Board's Edwards Lifesciences position peaked at $159M in Q3 2021.
  • 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.